Certara/$CERT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Certara
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Ticker
$CERT
Sector
Primary listing
Employees
1,546
Headquarters
Website
Certara Metrics
BasicAdvanced
$810m
-
-$0.10
1.54
-
Price and volume
Market cap
$810m
Beta
1.54
52-week high
$13.88
52-week low
$4.45
Average daily volume
4m
Financial strength
Current ratio
1.877
Quick ratio
1.704
Long term debt to equity
29.231
Total debt to equity
29.887
Interest coverage (TTM)
0.99%
Profitability
EBITDA (TTM)
94.029
Gross margin (TTM)
61.59%
Net profit margin (TTM)
-3.60%
Operating margin (TTM)
4.38%
Effective tax rate (TTM)
-210.15%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
0.81%
Return on equity (TTM)
-1.44%
Valuation
Price to revenue (TTM)
1.981
Price to book
0.79
Price to tangible book (TTM)
-4.27
Price to free cash flow (TTM)
13.176
Free cash flow yield (TTM)
7.59%
Free cash flow per share (TTM)
0.395
Growth
Revenue change (TTM)
6.40%
Earnings per share change (TTM)
400.05%
3-year revenue growth (CAGR)
6.82%
3-year earnings per share growth (CAGR)
4.19%
What the Analysts think about Certara
Analyst ratings (Buy, Hold, Sell) for Certara stock.
Certara Financial Performance
Revenues and expenses
Certara Earnings Performance
Company profitability
Certara News
AllArticlesVideos
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference
MarketBeat·1 week ago
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Business Wire·4 weeks ago
CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs